The UK's new clinical trials regulations enter into force on 28 April 2026, introducing mandatory transparency requirements for sponsors. These changes establish legally binding registration timelines, results publication obligations, and plain language summary provisions, with non-compliance constituting a criminal offence. This webcast brings together experts from across the UK clinical trial transparency landscape, including ISRCTN registry operations, sponsor operational perspectives, and industry stakeholders, to provide practical guidance on achieving compliance.
Attendees will learn how to navigate registration requirements, manage deferrals for commercially sensitive information, meet plain language summary obligations for participants, and build sustainable transparency practices beyond April. With fewer than 100 days until implementation, the countdown to compliance is on, and this session offers essential preparation strategies for organizations conducting clinical trials in the UK.
Registration Fees & Deadlines
Who Should Attend?
- Clinical trial sponsors and CROs conducting or planning trials in the UK
- Regulatory affairs professionals managing trial registration and disclosure compliance - Clinical operations teams implementing transparency workflows and systems
- Medical writing and communications professionals developing plain language summaries
- Quality assurance and compliance teams overseeing portfolio-wide transparency obligations
- Project managers coordinating multi-registry requirements
- Legal and information governance professionals managing participant data retention for results sharing
Audience Learning Level
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
Speakers
Benedict Evans
Manager, Clinical Trial Disclosure Regulations, Citeline
Benedict Evans is a regulatory professional with expertise in clinical trial disclosure, medical technology, and biotechnology. As disclosure regulations research manager at Citeline, Benedict works on the content development and expansion of TrialScope Intelligence, ensuring that sponsors have access to reliable, up-to-date regulatory insights to inform actionable regulatory intelligence. With a strong foundation in science, regulation, and project management, Benedict has worked across the biotech, life sciences, and medical technology sectors, helping organizations navigate regulatory requirements.
Proof of Attendance
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Questions
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email
support@raps.org